140 related articles for article (PubMed ID: 9001344)
21. Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.
El-kott AF; El-baz MA; Mokhtar AA
Int Urol Nephrol; 2006; 38(2):237-42. PubMed ID: 16868689
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
Kii T; Takiuchi H; Kawabe S; Gotoh M; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
Jpn J Clin Oncol; 2007 Aug; 37(8):583-9. PubMed ID: 17709606
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M
Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression.
Shibakita M; Tachibana M; Dhar DK; Ohno S; Kubota H; Yoshimura H; Kinugasa S; Masunaga R; Nagasue N
Clin Cancer Res; 2000 Dec; 6(12):4755-9. PubMed ID: 11156230
[TBL] [Abstract][Full Text] [Related]
26. Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression.
Kimos MC; Wang S; Borkowski A; Yang GY; Yang CS; Perry K; Olaru A; Deacu E; Sterian A; Cottrell J; Papadimitriou J; Sisodia L; Selaru FM; Mori Y; Xu Y; Yin J; Abraham JM; Meltzer SJ
Int J Cancer; 2004 Sep; 111(3):415-7. PubMed ID: 15221970
[TBL] [Abstract][Full Text] [Related]
27. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
28. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma.
Hirvikoski P; Kumpulainen E; Virtaniemi J; Johansson R; Haapasalo H; Marin S; Halonen P; Helin H; Raitiola H; Pukander J; Kellokumpu-Lehtinen P; Kosma VM
J Clin Oncol; 1997 Sep; 15(9):3111-20. PubMed ID: 9294474
[TBL] [Abstract][Full Text] [Related]
29. MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.
Minami T; Yuasa N; Miyake H; Takeuchi E; Nagai H; Ito M; Kiriyama A; Miyata K
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29272372
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.
Youssef EM; Matsuda T; Takada N; Osugi H; Higashino M; Kinoshita H; Watanabe T; Katsura Y; Wanibuchi H; Fukushima S
Cancer; 1995 Aug; 76(3):358-66. PubMed ID: 8625114
[TBL] [Abstract][Full Text] [Related]
32. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.
Shiozaki A; Nakashima S; Ichikawa D; Fujiwara H; Konishi H; Komatsu S; Kubota T; Okamoto K; Iitaka D; Shimizu H; Nako Y; Takemoto K; Kishimoto M; Otsuji E
Anticancer Res; 2013 Oct; 33(10):4329-35. PubMed ID: 24123000
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
Sheen-Chen SM; Eng HL; Chou FF; Chen WJ
Arch Surg; 1997 Mar; 132(3):264-7. PubMed ID: 9125025
[TBL] [Abstract][Full Text] [Related]
35. Polypoid carcinoma of the esophagus.
Mori M; Mimori K; Sadanaga N; Watanabe M; Kuwano H; Sugimachi K
Jpn J Cancer Res; 1994 Nov; 85(11):1131-6. PubMed ID: 7829398
[TBL] [Abstract][Full Text] [Related]
36. Assessment of proliferating cell nuclear antigen immunostaining in parotid tumors.
Takahashi M; Adachi T; Matsui R; Miyokawa N
Eur Arch Otorhinolaryngol; 1998; 255(6):311-4. PubMed ID: 9693928
[TBL] [Abstract][Full Text] [Related]
37. Proliferating cell nuclear antigen in needle biopsy specimens of prostatic carcinoma.
Naito S; Sakamoto N; Kotoh S; Goto K; Koga H; Hasegawa S; Matsumoto T; Kumazawa J
Eur Urol; 1994; 26(2):164-9. PubMed ID: 7525294
[TBL] [Abstract][Full Text] [Related]
38. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
Wu X; Zhang Z; Cai S
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
[TBL] [Abstract][Full Text] [Related]
39. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China.
Chen H; Wang LD; Guo M; Gao SG; Guo HQ; Fan ZM; Li JL
World J Gastroenterol; 2003 Jan; 9(1):16-21. PubMed ID: 12508343
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Uesugi N; Sasaki R; Kanno S; Saito K
Oncology; 1997; 54(5):407-13. PubMed ID: 9260603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
